COMP <GO>
BSX vs MDLN // FREE CASH FLOW YIELD
Boston Scientific Corporation (NYSE) VS. Medline Inc. (NASDAQ) • 15-METRIC TALLY: BSX 9
— MDLN 2
▲ FREE CASH FLOW YIELD LEADER: BSX
LAST: $44.32 (+5.57%) • MKT CAP: $60.84B
fcf-yield
5.91%
LAST: $33.63 (+4.70%) • MKT CAP: $42.23B
fcf-yield
3.08%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BSX VS. MDLN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BSX | MDLN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.20% | 8.20% | +1.00 | BSX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.8x | 20.3x | -4.50 | BSX | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 5.91% | 3.08% | +2.83 | BSX | /fcf-yield <GO> |
| Operating Margin | 18.00% | 7.80% | +10.20 | BSX | /operating-margins <GO> |
| Net Profit Margin | 14.00% | 68.00% | -54.00 | MDLN | /net-margins <GO> |
| Revenue Growth (YoY) | 19.90% | 11.50% | +8.40 | BSX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.77 | 2.50 | +0.27 | BSX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | BSX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.8 | 32.5 | +7.30 | BSX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 1.11 | -0.12 | MDLN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.5x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $60.84B | $42.23B | $18.61B | BSX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BSX REV | MDLN REV | BSX GROSS % | MDLN GROSS % | BSX FCF | MDLN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $20.07B | $28.43B | 69.0% | 26.4% | $3.66B | $1.30B |
| FY 2024 | $16.75B | $25.51B | 68.6% | 27.3% | $2.65B | $1.42B |
| FY 2023 | $14.24B | $23.23B | — | — | $1.86B | $639.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BSX // BETA 0.99
MDLN // BETA 1.11